Mitigating Covid-19 through a Hybrid Decentralized Clinical Trials Approach

The Covid-19 pandemic has presented the industry with many risks and challenges to the management of clinical trials. For many, the mitigation of these issues has accelerated the implementation of decentralized approaches to monitoring and management of clinical trials. In this webinar, we will discuss:

        • What risks and challenges COVID-19 has presented
        • Ways in which these can be addressed
        • Rho as a case study

Marina Acosta Enslen

Marina Acosta Enslen

Associate Director, Clinical Management

Marina Acosta Enslen has been involved in the conduct of clinical trials for 20 years, working in academia, pharmaceutical, and CRO markets. She has experience working on NIH and industry funded Phase 1 – 4 global clinical trials. Much of her career has been focused in infectious disease, primarily HIV/AIDS and HPV research providing clinical trial coordination, monitoring and clinical team leadership. Ms. Acosta Enslen’s broad experience from multiple perspectives and strong understanding of clinical trial management particular to infectious disease trials has allowed her to successfully lead teams. Prior to joining Rho, Ms. Acosta Enslen’s experience included the conduct…

Nick Poulson

Nick Poulson, Ph.D

Senior Project Manager

With almost a decade of clinical trial experience, Dr. Nick Poulson has managed, monitored, and coordinated Phase 2 through Phase 4 clinical trials across various therapeutic areas, especially pain. Holding multiple roles across more than 5 osteoarthritis studies, Dr. Poulson currently serves as Senior Project Manager of an Osteoarthritis Program. Over the course of this program, Dr. Poulson was able to reduce enrollment timelines by 2-3 months by coordinating and guiding his team through a fast-paced startup timeline to ensure the activation of most sites before enrollment for each study began. Always giving 110%, Dr. Poulson prides himself on delivering…

Fran Sawyer

Fran Sawyer

Clinical Team Lead

Fran Sawyer has over 13 years of industry experience including serving as a lead on a Vaccine, Cardiovascular, Pain, COPD, and Osteoarthritis trials. Her other study indications include high risk vascular disease and lowering LDL, atrial fibrillation, asthma, graft versus host, breast cancer, and sickle cell disease. She joined Rho in 2014 and is a seasoned leader with training and mentoring experience. Ms. Sawyer has a strong understanding of clinical trial management and delivery requirements that has allowed her teams to successfully meet data timeline deliverables for various multi-center trials. She is also adept in all aspects of GCPs, regulatory…